T36.6 Poisoning by, adverse effect of and underdosing of rifampicins

Name of the Condition

• Poisoning by, adverse effect of and underdosing of rifampicins

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to rifampicins. It includes cases where rifampicin exposure leads to harmful effects, unintended reactions, or insufficient therapeutic levels. Documentation should specify the type of rifampicin, intent (e.g., accidental, therapeutic error), and encounter details.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose of rifampicins, incorrect administration, or allergic reactions. Underdosing occurs when therapeutic levels are not achieved, often due to dosing errors, non-adherence, or inadequate prescription. Adverse effects can stem from drug interactions, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

• Prior history of rifampicin allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., hepatotoxicity).
• Underdosing: Persistent infection, treatment failure.

Diagnosis

Evaluation includes patient history of rifampicin use, clinical assessment of symptoms, and laboratory tests (e.g., liver function, drug levels). Documentation must clarify the nature of the event (poisoning, adverse effect, or underdosing) to guide coding.

Treatment Options

Management depends on the event type: poisoning may require decontamination or supportive care; adverse effects may need discontinuation or symptom management; underdosing may involve dose adjustment or adherence support. Consultation with a specialist (e.g., toxicology, infectious disease) may be necessary.

Prognosis and Follow-Up

Prognosis varies by severity and timely intervention. Underdosing may lead to treatment failure, while severe poisoning or adverse effects can cause organ damage. Follow-up includes monitoring for recurrence, adherence, and organ function.

Complications

• Severe hepatotoxicity or renal impairment from adverse effects.
• Treatment failure or drug resistance from underdosing.
• Anaphylaxis or systemic reactions from poisoning.

Lifestyle & Prevention

• Educate patients on proper dosing and adherence.
• Avoid drug interactions (e.g., with anticoagulants, antiretrovirals).
• Monitor liver function in high-risk patients.
• Use rifampicins only as prescribed.

When to Seek Professional Help

Seek care for severe symptoms (e.g., anaphylaxis, organ dysfunction), suspected overdose, or persistent infection despite treatment. Immediate medical attention is critical for life-threatening reactions.

Tips for Medical Coders

Document the specific rifampicin event (poisoning, adverse effect, or underdosing) and encounter details. Ensure clarity on intent (e.g., accidental, therapeutic error) and clinical context to support accurate coding.